juillet 2024

Pulse Biosciences

Pulse Biosciences

Lead Agent (ATM Offering)

Canaccord Genuity Acts as Lead Agent to Pulse Biosciences on its US$60m At-the-Market Offering

More Like This

US$92m

décembre 2024

Candel Therapeutics

Joint Bookrunner (CMPO)
décembre 2024

Neuronetics

Financial Advisor to Neuronetics on its Merger with Greenbrook TMS
novembre 2024

UCB

Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma

Afficher les transactions Healthcare